3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasm Metastasis
7
Lung Neoplasms
4
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Sarcoma
2
Pain
2
Melanoma
2
Liver Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Osteosarcoma
1
Neoplasms
1
Menorrhagia
1
Lymphoma, T-Cell
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leiomyoma
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Neoplasms
1
Interventions
3-Iodobenzylguanidine
3
cabozantinib
2
tipifarnib
1
pembrolizumab
1
pazopanib
1
lutetium Lu 177 dotatate
1
lenvatinib
1
guadecitabine
1
fostamatinib
1
copper dotatate CU-64
1
atezolizumab
1
Temozolomide
1
Surgical Procedures, Operative
1
Sunitinib
1
Phenoxybenzamine
1
Nivolumab
1
Lutetium-177
1
Lutetium
1
Iodine-131
1
Everolimus
1
Erlotinib Hydrochloride
1
Doxazosin
1
Capecitabine
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Pheochromocytoma
×
Cryosurgery
×
Clear all
No trials found.